Anti-C1q antibodies and pregnancy outcomes study
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at a specific antibody (anti-C1q) in pregnant women, including those with normal pregnancies, preeclampsia (high blood pressure and protein in urine after 20 weeks), or autoimmune conditions like lupus or antiphospholipid syndrome. The goal is to understand how this antibody might affect pregnancy and help guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You either have a normal pregnancy, preeclampsia, or an autoimmune condition (like lupus, antiphospholipid syndrome, or autoimmune thyroiditis).
- You are willing to return to the hospital about 40 days after giving birth.
- You do not have a blood infection from a virus or bacteria.
- You are able to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study is looking at pregnancy outcomes in people who are pregnant and either have antiphospholipid antibody syndrome (APS) or do not have APS but do have prior full-term pregnancies. It may help doctors understand risks and how to manage pregnancies in these groups.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This study looks at people with preeclampsia during pregnancy and how their lung blood pressure and related symptoms change after delivery. It may help doctors better monitor and manage postpartum risks, especially involving the heart and lungs.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.